The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction

Regiane Stafim da Cunha1, Carolina Amaral Bueno Azevedo1, Carlos Alexandre Falconi2

  • 1Experimental Nephrology Laboratory, Basic Pathology Department, Universidade Federal do Paraná, Curitiba 81531-980, Brazil.

Toxins
|March 24, 2022
PubMed

Insights

Uremic toxins, accumulating in chronic kidney disease (CKD), interact with albumin and transporters, affecting drug efficacy. Understanding these interactions is crucial for managing CKD comorbidities and treatment.

Area of Science:

  • Nephrology
  • Pharmacology
  • Biochemistry

Background:

  • Uremic toxins accumulate in chronic kidney disease (CKD), contributing to kidney dysfunction and comorbidities.
  • Dialysis partially removes these toxins, but drug interactions complicate their management.
  • Protein-bound uremic toxins (PBUTs) and membrane transporter substrates are key areas of concern.

Purpose of the Study:

  • To explore interaction mechanisms between uremic toxins, albumin, and membrane transporters.
  • To investigate the relationship between these interactions and drugs used in clinical practice.
  • To provide insights into managing drug therapy in CKD patients.

Main Methods:

  • Literature review of studies on uremic toxin-protein binding.
  • Analysis of research on uremic toxin-transporter interactions.
  • Examination of drug-toxin-protein/transporter interplay.

Main Results:

  • Uremic toxins exhibit high affinity for albumin, influencing drug binding and disposition.
  • Membrane transporters mediate toxin transport, with potential for drug competition and altered activity.
  • Drug interactions with albumin and transporters can modify uremic toxin levels and effects.

Conclusions:

  • Interactions between uremic toxins, albumin, and transporters significantly impact drug therapy in CKD.
  • Understanding these mechanisms is essential for optimizing treatment strategies and patient outcomes.
  • Further research is needed to fully elucidate these complex relationships.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.8K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
322
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
7.1K
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
4.3K
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
708
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
251